SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates INBX, HAYN, EVBG, KAMN
![GlobeNewswire](../../../Content/images/providers/GN.png)
Inhibrx Biosciences, Inc. (INBX)
Company Research
Source: GlobeNewswire
NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Inhibrx, Inc. (NASDAQ: INBX)’s sale to Sanofi. Under the terms of the proposed transaction, for each Inhibrx share, Inhibrx shareholders will receive $30.00 in cash, a contingent value right of $5.00, conditioned upon the achievement of a regulatory milestone, and 0.25 shares of a new publicly traded company that will retain Inhibrx’s non-INBRX-101 assets. If you are a Inhibrx shareholder, click here to learn more about your rights and options. Haynes International, Inc. (NASDAQ: HAYN)’s sale to North American Stainless for $61.00 per share in cash. If you are a Haynes shareholder, click here to learn more about your rights and options. Everbridge, Inc. (NASDAQ: EVBG)’s sale to Thoma Bravo for $28.60 per share in cash. If yo
Show less
Read more
Impact Snapshot
Event Time:
INBX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INBX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INBX alerts
High impacting Inhibrx Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
INBX
News
- Press Release: Sanofi completes acquisition of Inhibrx, Inc. [Yahoo! Finance]Yahoo! Finance
- Inhibrx gets stockholders approval to sell INBRX-101 to Sanofi [Seeking Alpha]Seeking Alpha
- Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to SanofiPR Newswire
- Single Domain Antibody Platforms MarketResearch 2024-2031: Strategic Collaborations Driving Expansion, Focus on Pioneering Cancer Treatments, US Leads Innovations [Yahoo! Finance]Yahoo! Finance
- Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-OffPR Newswire
INBX
Earnings
- 2/28/24 - Miss
INBX
Sec Filings
- 6/10/24 - Form 15-12G
- 6/3/24 - Form SC
- 6/3/24 - Form 4
- INBX's page on the SEC website